Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Causes

    ... De Novo MDS The cause of most MDS cases is ...

    Topic section last updated 04/06/2018 - 12:27pm.

  2. Promising news for older AML patients

    ... was effective among patients with both primary de novo AML (68%) and secondary AML (related to myelodysplasia or ...

    Article last updated 07/19/2017 - 11:19am.

  3. CASCADE (SGN33A-005)

    ... untreated, cytologically/histologically confirmed de novo or secondary AML according to World Health Organization (WHO) ...

    Clinical Trial last updated 06/19/2017 - 2:43pm.

  4. Focal Adhesion Kinase as a Potential Target in AML and MDS

    ... who transformed from MDS compared with those with de novo AML. Co-culture with mesenchymal stromal cells (MSCs) increased FAK ...

    Research Article last updated 03/22/2017 - 10:20am.

  5. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

    ... syndromes (MDS) have worse outcomes than de novo MDS (d-MDS), some t-MDS patients have an indolent course. Most MDS ...

    Research Article last updated 03/09/2017 - 1:27pm.

  6. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... 72.3 [15.6] years), 55 (64.0%) had MDS, 21 (24.4%) had de novo AML, and 10 (11.6%) had AML and a history of MDS. Rheumatoid arthritis ...

    Research Article last updated 02/21/2017 - 10:55am.

  7. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium

    ... While therapy-related (t)-MDS has worse outcomes than de novo MDS (d-MDS), some t-MDS patients have an indolent course. Most MDS ...

    Research Article last updated 02/03/2017 - 10:09am.

  8. Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

    ... 72.3 [15.6] years), 55 (64.0%) had MDS, 21 (24.4%) had de novo AML, and 10 (11.6%) had AML and a history of MDS. Rheumatoid arthritis ...

    Research Article last updated 02/03/2017 - 1:25pm.

  9. Therapy-related myelodysplastic syndromes, or are they?

    ... monotherapy, biologically and clinically resemble de novo (d)-MDS more than t-MDS, and therefore may not be truly ...

    Research Article last updated 01/26/2017 - 10:08am.

  10. The National Myelodysplastic Syndromes Natural History Study

    ... bone marrow assessments, or diagnosed with de novo or therapy-related MDS within 6-months of enrollment per the ...

    Clinical Trial last updated 02/23/2017 - 1:36pm.